What are the recommended topical treatments for pressure ulcers (bedsores) based on their stage?

Topical Treatment for Bedsores

Use hydrocolloid or foam dressings as first-line topical treatment for pressure ulcers to reduce wound size. 1

Primary Dressing Recommendations

The American College of Physicians 2015 guideline provides the clearest evidence-based approach to topical treatment:

Hydrocolloid or foam dressings are superior to gauze dressings for reducing wound size (weak recommendation, low-quality evidence) 1. These dressings maintain a moist wound environment at the wound/dressing interface, which is one of only three treatment recommendations supported by multiple prospective randomized trials 2.

• Hydrocolloid dressings show better wound size reduction compared to gauze
• Foam dressings (hydrocellular or polyurethane) achieve complete wound healing rates similar to hydrocolloid dressings
• Both are cost-effective alternatives to more expensive options like platelet-derived growth factor (PDGF) dressings 1

Dressing Selection Algorithm

For all stages of pressure ulcers (Stage 2-4):

1. Start with hydrocolloid or foam dressings as standard care
2. Avoid gauze dressings—they are inferior for wound size reduction 1
3. Avoid dextranomer paste—it is inferior to other dressings 1

Important caveat: The evidence does not clearly differentiate effectiveness by ulcer stage, so the same dressing approach applies across stages 1.

Topical Agents to Avoid or Use Cautiously

Do NOT use routinely:

• Povidone-iodine: May actually reduce healing rates compared to non-antimicrobial alternatives (fewer ulcers healed with povidone-iodine vs. protease-modulating dressings RR 0.78, and vs. hydrogel RR 0.64) 3
• Rifamycin and povidone-iodine solution: Recent 2025 data suggests these may worsen pressure ulcer condition 4

Insufficient evidence for:

• Topical antibiotics and antiseptics show no clear benefit for healing 5
• Debriding enzymes, topical phenytoin, zinc supplementation—all lack sufficient evidence 1
• Hyperbaric oxygen therapy—insufficient evidence despite common use 1

Topical Agents with Limited Supporting Evidence

Platelet-derived growth factor (PDGF): Shows some benefit for more severe ulcers compared to placebo, but is not recommended due to high cost when hydrocolloid/foam dressings are equally effective and far less expensive 1.

Pine resin salve: One low-quality study suggests potential benefit (RR 2.83 vs. hydrocolloid), but evidence is too limited for routine recommendation 3.

Adjunctive Therapy Consideration

Electrical stimulation can be added as adjunctive therapy to accelerate wound healing for Stage 2-4 ulcers (weak recommendation, moderate-quality evidence) 1. However, this is not a topical treatment per se—it's used alongside standard dressings.

• Most common adverse effect: skin irritation
• Frail elderly patients are more susceptible to adverse events 1

Critical Wound Preparation Steps

Before applying any dressing:

1. Remove pressure source (repositioning, pressure-relief devices)
2. Cleanse the wound with hand washing and appropriate wound cleansing
3. Debride necrotic tissue if present 2
4. Assess for infection: If advancing cellulitis, sepsis, or osteomyelitis present, institute systemic antibiotics—not topical antimicrobials 2

Common Pitfalls

• Using gauze dressings: These are outdated and less effective 1
• Applying topical antiseptics routinely: No clear healing benefit and may cause harm 3, 5
• Choosing expensive biologics first: PDGF and other growth factors lack sufficient evidence to justify their cost over standard dressings 1
• Expecting topical treatment alone to heal ulcers: Pressure relief and nutritional support (protein/amino acid supplementation) are equally critical 1

Evidence Quality Context

The overall evidence base is weak—most recommendations are based on low or very low-certainty evidence due to small studies, high risk of bias, and imprecision 3, 6. The 2017 Cochrane network meta-analysis found the evidence too sparse to confidently rank interventions 3. However, the ACP guideline remains the most authoritative source, and hydrocolloid/foam dressings represent the best-supported, cost-effective approach available.

Recent 2025 data suggests multilayer silicone foam dressing may be most effective, particularly for suspected deep tissue injury 4, though this requires confirmation in larger trials.